




Hava Klemperer Meretzki - Vice Chairman-National Council at Israel Bar Association



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Hava Klemperer Meretzki
Vice Chairman-National Council at Israel Bar Association



Overview
Relationships Paths
Education Career History Boards & Committees Public Holdings Awards & Honors 


Hava Klemperer Meretzki
Vice Chairman-National Council at Israel Bar Association



 Overview



Age



47
                                  (Born 1970)
                                              




Awards



1





Board Seats



4





Number of Relationships



                This person is connected to 69 people.
              






 Relationships
              See Details




Zami Aberman

Chairman & Co-Chief Executive Officer at Pluristem Therapeutics Inc.




Yaky Yanay

Director, President & Co-Chief Executive Officer at Pluristem Therapeutics Inc.





Doron Shorrer

Chairman & Chief Executive Officer at Shorrer International Ltd.




Meir Linzen

Senior Managing Partner at Herzog Fox Neeman





Moria Kwiat

Research Fellow, Department of Material & Nanosciences at Tel Aviv University - School of Chemistry




Israel Ben Yoram

Chief Executive Officer at Zonbit Ltd.





Isaac  Braun

Member, Board of Directors at Pluristem Therapeutics Inc.




Mark Germain

Managing Director at The Olmsted Group





Nachum  Rosman

Chief Executive Officer at Simba Ltd.




Adi Goldin

Associate at Israel Bar Association







See 59 more listings with RelSci Professional.

Start My Free Trial ➤








See 59 More 


 


 Paths to Hava Klemperer Meretzki



            Hava Klemperer Meretzki          




 You



 Connections via Relationship Science



 Hava Klemperer Meretzki






Sync your contacts to see how you can connect with Hava Klemperer Meretzki.

Start My Free Trial ➤








See  More 


 


 Educational Background



Bachelor's Degree in Law 
Class of 1991 


The Hebrew University of Jerusalem

                  The Hebrew University of Jerusalem is Israel's second oldest university established in 1918, 30 years before the State of Israel. The Hebrew University has three campuses in Jerusalem and one in Rehovot. The world's largest Jewish studies library is located on its Edmond J. Safra Givat Ram campus.                





 Career History



Partner

                                    Current                


Meretzki-Tavor






Vice Chairman-National Council

                                    Current                


Israel Bar Association







 Boards & Committees



Corporate Boards ▾




Member, Board of Directors

                    2003 - Current                  


Pluristem Therapeutics Inc.

                    Pluristem Therapeutics, Inc. is a biotechnology company engages in the provision of cell therapy development. It focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.                  




Director

                    Prior                  


The Israel Electric Corp. Ltd.

                    Israel Electric Corp. Ltd. generates, transmits, sells and distributes electricity. It offers its services to the households, industrial, public and commercial buildings, and bulk water pumping and agriculture. The company was founded on March 29, 1923 and is headquartered in Haifa, Israel.                  




Director

                    Prior                  


Israel Electric Co.






Non-Profit Boards ▾




Vice Chairman, National Council

                    1993 - ?                  


Israel Bar Association







 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Awards & Honors




                  Professional Certification                

                  1993
                


Admitted to the Israel Bar







 Other Affiliations




              Hava Klemperer Meretzki is affiliated with
                            Meretzki-Tavor, Israel Bar Association, Pluristem Therapeutics Inc., The Israel Electric Corp. Ltd., Israel Electric Co., Israel Bar Association.
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤















Hava Meretzki |  | Decypha

































Sign In
|
Welcome  Guest 









 







Regions

GCC
                                |
                                    Levant
                                |
                                    MENA
                                |
                                    North Africa




GCC

Bahrain
                            |
                            Kuwait
                            |
                            Oman
                            |
                            Qatar
                            |
                            Saudi Arabia
                            |
                            United Arab Emirates




Levant

Iraq
                            |
                            Jordan
                            |
                            Lebanon
                            |
                            Palestine




North Africa

Egypt
                            |
                            Libya
                            |
                            Morocco
                            |
                            Tunisia




Others

Iran
                            |
                            Turkey
                            |
                            United Kingdom
                            |
                            United States












Advanced Search















News






Markets






Companies






Research






Funds






Fixed Income






Money Markets






Commodities






FX






Economics






Analysis






More











Sign In
Membership
Customize Your Decypha
Logout
Welcome
Decypha Alerts












Home




People Profiles




People Profile



Hava Meretzki Profile














Full Name:

                                                    Hava Meretzki
                                                







Country:











Biography


                                                    Ms. Meretzki became a director of the Company in October, 2003. Ms. Meretzki is an attorney and is a partner in the law firm of Meretzki - Tavor in Haifa,... 











Designations




Date
Designation
Entity
Entity Description
Country




2003


Pluristem Therapeutic

--

--









Check all the  individuals in 
Check The List






Request a Trial
















Title:*


Select
Mr
Mrs
Ms
Miss
Dr
Prof




First Name:*



Last Name:*



Job Title:*


Select
 Asset Managers
 Corporate Banks
 Investment Managers
 Wealth Managers
 Consultants & Advisors
 Legal Practioners
 Academics
 Hedge Funds
 Private Equity Analysts
 Traders
 Equity Research Analysts




Phone:*



Company:*




Email:*




Country:*


Select

                                                Afganistan
                                        

                                                Albania
                                        

                                                Algeria
                                        

                                                American Samoa
                                        

                                                Andorra
                                        

                                                Angola
                                        

                                                Anguilla
                                        

                                                Antarctica
                                        

                                                Antigua and Barbuda
                                        

                                                Argentina
                                        

                                                Armenia
                                        

                                                Aruba
                                        

                                                Australia
                                        

                                                Austria
                                        

                                                Azerbaijan
                                        

                                                Bahamas
                                        

                                                Bahrain
                                        

                                                Bangladesh
                                        

                                                Barbados
                                        

                                                Belarus
                                        

                                                Belgium
                                        

                                                Belize
                                        

                                                Benin
                                        

                                                Bermuda
                                        

                                                Bhutan
                                        

                                                Bolivia
                                        

                                                Bosnia and Herzegovina
                                        

                                                Botswana
                                        

                                                Bouvet Island
                                        

                                                Brazil
                                        

                                                British Indian Ocean Territory
                                        

                                                Brunei
                                        

                                                Bulgaria
                                        

                                                Burkina Faso
                                        

                                                Burundi
                                        

                                                Cambodia
                                        

                                                Cameroon
                                        

                                                Canada
                                        

                                                Cape Verde
                                        

                                                Cayman Islands
                                        

                                                Central African Republic
                                        

                                                Chad
                                        

                                                Chile
                                        

                                                China
                                        

                                                Christmas Island
                                        

                                                Cocos (Keeling) Islands
                                        

                                                Colombia
                                        

                                                Comoros
                                        

                                                Congo
                                        

                                                Cook Islands
                                        

                                                Costa Rica
                                        

                                                Cote D'Ivoire (Ivory Coast)
                                        

                                                Croatia (Hrvatska)
                                        

                                                Cuba
                                        

                                                Curacao
                                        

                                                Cyprus
                                        

                                                Czech Republic
                                        

                                                Czechoslovakia (former)
                                        

                                                Denmark
                                        

                                                Djibouti
                                        

                                                Dominica
                                        

                                                Dominican Republic
                                        

                                                East Timor
                                        

                                                Ecuador
                                        

                                                Egypt
                                        

                                                El Salvador
                                        

                                                Equatorial Guinea
                                        

                                                Eritrea
                                        

                                                Estonia
                                        

                                                Ethiopia
                                        

                                                Falkland Islands (Malvinas)
                                        

                                                Faroe Islands
                                        

                                                Fiji
                                        

                                                Finland
                                        

                                                France
                                        

                                                France, Metropolitan
                                        

                                                French Guiana
                                        

                                                French Polynesia
                                        

                                                French Southern Territories
                                        

                                                Gabon
                                        

                                                Gambia
                                        

                                                Georgia
                                        

                                                Germany
                                        

                                                Ghana
                                        

                                                Gibraltar
                                        

                                                Greece
                                        

                                                Greenland
                                        

                                                Grenada
                                        

                                                Guadeloupe
                                        

                                                Guam
                                        

                                                Guatemala
                                        

                                                Guernsey
                                        

                                                Guinea
                                        

                                                Guinea-Bissau
                                        

                                                Guyana
                                        

                                                Haiti
                                        

                                                Heard and McDonald Islands
                                        

                                                Honduras
                                        

                                                Hong Kong
                                        

                                                Hungary
                                        

                                                Iceland
                                        

                                                India
                                        

                                                Indonesia
                                        

                                                Iran
                                        

                                                Iraq
                                        

                                                Ireland
                                        

                                                Isle of Man
                                        

                                                Israel
                                        

                                                Italy
                                        

                                                Jamaica
                                        

                                                Japan
                                        

                                                Jersey
                                        

                                                Jordan
                                        

                                                Kazakhstan
                                        

                                                Kenya
                                        

                                                Kiribati
                                        

                                                Kuwait
                                        

                                                Kyrgyzstan
                                        

                                                Laos
                                        

                                                Latvia
                                        

                                                Lebanon
                                        

                                                Lesotho
                                        

                                                Liberia
                                        

                                                Libya
                                        

                                                Liechtenstein
                                        

                                                Lithuania
                                        

                                                Luxembourg
                                        

                                                Macau
                                        

                                                Macedonia
                                        

                                                Madagascar
                                        

                                                Malawi
                                        

                                                Malaysia
                                        

                                                Maldives
                                        

                                                Mali
                                        

                                                Malta
                                        

                                                Marshall Islands
                                        

                                                Martinique
                                        

                                                Mauritania
                                        

                                                Mauritius
                                        

                                                Mayotte
                                        

                                                Mexico
                                        

                                                Micronesia
                                        

                                                Moldova
                                        

                                                Monaco
                                        

                                                Mongolia
                                        

                                                Montenegro
                                        

                                                Montserrat
                                        

                                                Morocco
                                        

                                                Mozambique
                                        

                                                Myanmar
                                        

                                                Namibia
                                        

                                                Nauru
                                        

                                                Nepal
                                        

                                                Netherlands
                                        

                                                Netherlands Antilles
                                        

                                                Neutral Zone
                                        

                                                New Caledonia
                                        

                                                New Zealand (Aotearoa)
                                        

                                                Nicaragua
                                        

                                                Niger
                                        

                                                Nigeria
                                        

                                                Niue
                                        

                                                Norfolk Island
                                        

                                                North Korea
                                        

                                                Northern Mariana Islands
                                        

                                                Norway
                                        

                                                Oman
                                        

                                                Pakistan
                                        

                                                Palau
                                        

                                                Palestine
                                        

                                                Panama
                                        

                                                Papua New Guinea
                                        

                                                Paraguay
                                        

                                                Peru
                                        

                                                Philippines
                                        

                                                Pitcairn
                                        

                                                Poland
                                        

                                                Portugal
                                        

                                                Puerto Rico
                                        

                                                Qatar
                                        

                                                Reunion
                                        

                                                Romania
                                        

                                                Russia
                                        

                                                Rwanda
                                        

                                                S. Georgia and S. Sandwich Isls.
                                        

                                                Saint Kitts and Nevis
                                        

                                                Saint Lucia
                                        

                                                Saint Vincent and the Grenadines
                                        

                                                Samoa
                                        

                                                San Marino
                                        

                                                Sao Tome and Principe
                                        

                                                Saudi Arabia
                                        

                                                Senegal
                                        

                                                Serbia
                                        

                                                Seychelles
                                        

                                                Sierra Leone
                                        

                                                Singapore
                                        

                                                Slovak Republic
                                        

                                                Slovenia
                                        

                                                Solomon Islands
                                        

                                                Somalia
                                        

                                                South Africa
                                        

                                                South Korea
                                        

                                                South Sudan
                                        

                                                Spain
                                        

                                                Sri Lanka
                                        

                                                St. Helena
                                        

                                                St. Pierre and Miquelon
                                        

                                                Sudan
                                        

                                                Suriname
                                        

                                                Svalbard and Jan Mayen Islands
                                        

                                                Swaziland
                                        

                                                Sweden
                                        

                                                Switzerland
                                        

                                                Syria
                                        

                                                Taiwan
                                        

                                                Tajikistan
                                        

                                                Tanzania
                                        

                                                Thailand
                                        

                                                Togo
                                        

                                                Tokelau
                                        

                                                Tonga
                                        

                                                Trinidad and Tobago
                                        

                                                Tunisia
                                        

                                                Turkey
                                        

                                                Turkmenistan
                                        

                                                Turks and Caicos Islands
                                        

                                                Tuvalu
                                        

                                                US Minor Outlying Islands
                                        

                                                USSR (former)
                                        

                                                Uganda
                                        

                                                Ukraine
                                        

                                                United Arab Emirates
                                        

                                                United Kingdom
                                        

                                                United States
                                        

                                                Uruguay
                                        

                                                Uzbekistan
                                        

                                                Vanuatu
                                        

                                                Vatican City State (Holy See)
                                        

                                                Venezuela
                                        

                                                Vietnam
                                        

                                                Virgin Islands (British)
                                        

                                                Virgin Islands (U.S.)
                                        

                                                Wallis and Futuna Islands
                                        

                                                Western Sahara
                                        

                                                Yemen
                                        

                                                Yugoslavia
                                        

                                                Zaire
                                        

                                                Zambia
                                        

                                                Zimbabwe
                                        




Comments:





*Required Fields


 

 Submit








Already Registered?








Login attempt was not successful. Please try again








Username/ Email:



Password:





Enter Characters:















 

 Login





 Forget your password?
























By Job Title


Asset Managers |
                                    Corporate Banks |
                                    Investment Managers |
                                    Wealth Managers |
                                    Consultants & Advisors |
                                    Legal Practitioners |
                                    Academics |
                                    Hedge Funds |
                                    Private Equity Analysts |
                                    Traders |
                                    Equity Research Analysts


By Scope


Equity |
                                    Fixed Income |
                                    Funds |
                                    Excel  |
                                    Analytical Tools  |
                                    Markets  |
                                    Prices  |
                                    Money Market |
                                    News |
                                    Industry |
                                    IPOs |
                                    Mergers & Acquisitions |
                                    Commodities |
                                    Economics



Covered Countries and Exchanges

















Add Your Company | 
                                        Add Yourself | 
                                        Terms and Conditions | 
                                        Privacy Policy | 
                                        About DirectFN









Copyright ©  DirectFN. All Rights Reserved.











Data Not Available









Login











Login attempt was not successful. Please try again


Username/ Email:


Password:



Enter Characters:











 Forget your password?











Back to Top

Support & Feedback


Ask for free trial









Request a Trial
















Title:*


Mr
Mrs
Ms
Miss
Dr
Prof




First Name:*



Last Name:*



Email:*




Phone:*



Promo. Code:



Country:*


Select
Afganistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'Ivoire (Ivory Coast)
Croatia (Hrvatska)
Cuba
Curacao
Cyprus
Czech Republic
Czechoslovakia (former)
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia
New Zealand (Aotearoa)
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
S. Georgia and S. Sandwich Isls.
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
US Minor Outlying Islands
USSR (former)
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City State (Holy See)
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe




Company:*



Job Title:


Select
 Academics
 Asset Managers
 Consultants & Advisors
 Corporate Banks
 Equity Research Analysts
 Hedge Funds
 Investment Managers
 Legal Practioners
 Private Equity Analysts
 Traders
 Wealth Managers




Comments:




*Required Fields


 

 Submit



















Contact Us












Hello ,Please use the below form for
                            Product support & feedback


Name :  *  


Email:  * 


Phone Number :  * 






Preferred contact method :
Email
Phone











Technical Support 24x7: +94 112 314900 / slhops@directfn.net
Your Account Manager is, , , 






















 Get a Decypha Membership to view this content..................







Get a Decypha Membership


 Get the membership of Decypha Premium Package to access more exciting features including advanced analytical tools and the Pro 10 package. Pro 10 is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire.

All you need to access these valuable features is to click on the Get a membership button and submit your details to our sales team.















Upgrade your Membership


 Account is not entitled to view this information.

 Please contact your account manager to upgrade your Membership.

Email :  support@decypha.com






 Register to view this content..................







 Decypha Free Registration


Register free with Decypha and get access to real-time price information and many other features including Technical Scanner, Fundamental Screener etc.

Just click the Registration button, submit your details and get registered for free.








 

   Shai Meretzki | Pluristem Therapeutics Inc. | ZoomInfo.com


PSTI Hava Klemperer Meretzki Insider Trades for Pluristem Therapeutics Inc.


































X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

White House briefs reporters after Spicer quits as press secretary: live blog »
        




Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Pluristem Therapeutics Inc.

                  NASDAQ: PSTI
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Pluristem Therapeutics Inc.



Market open
 --Real time quotes
Jul 21, 2017, 2:03 p.m.


PSTI

/quotes/zigman/108591/composite


$
1.20




Change

+0.02
+1.69%

Volume
Volume 99,194
Real time quotes








/quotes/zigman/108591/composite
Previous close

$
			1.18
		


$
				1.20
			
Change

+0.02
+1.69%





Day low
Day high
$1.19
$1.25










52 week low
52 week high

            $1.04
        

            $1.85
        


















Insider Activity


Individual




Hava Klemperer Meretzki



Ms. Hava K. Meretzki is Partner at Meretzki-Tavor and Vice Chairman-National Council at Israel Bar Association. She is on the Board of Directors at Pluristem Therapeutics, Inc.
She received her undergraduate degree from The Hebrew University of Jerusalem.



Transactions


Date
Shares
Transaction
Value





12/29/2016
45,000


 
Award at $0 per share.


0


01/05/2016
35,000


 
Award at $0 per share.


0


01/08/2015
35,000


 
Award at $0 per share.


0


12/26/2013
35,000


 
Award at $0 per share.


0


06/27/2013
50,000


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Zami  Aberman 
Chairman & Co-Chief Executive Officer




Mr. Yaky  Yanay 
President, Co-Chief Executive Officer & Director




Mr. Erez  Egozi 
Chief Financial Officer & Treasurer




Dr. Esther  Lukasiewicz-Hagai 
Vice President-Clinical & Medical Affairs




Dr. Racheli  Ofir 
Vice President-Research & Intellectual Property




Dr. Hillit Mannor Shachar 
Vice President-Business Development




Dr. Moria  Kwiat 
Director




Ms. Hava Klemperer Meretzki 
Director




Mr. Isaac  Braun 
Director




Mr. Mark S. Germain 
Director




Mr. Efrat  Kaduri 
Manager-Investor & Public Relations




Ms. Karine  Kleinhaus 
Vice President-North America Division & IR Contact




Ms. Efrat  Livne-Hadass 
Vice President-Human Resources




Mr. Doron  Shorrer 
Independent Director




Mr. Israel  Ben-Yoram 
Independent Director




Mr. Nachum  Rosman 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




2:11 PM EDT
July 21, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
2:10pGold logs highest finish in a month, up over 2% for the week 
2:10pMicrosoft is challenging Amazon for cloud throne
2:10pAm I entitled to a spousal benefit?
2:10pWhite House briefs reporters after Spicer quits as press secretary: live blog
2:07pNot even free money can make some people go to the gym 
2:07p10 seriously inappropriate things you should never (ever) say to a co-worker
2:06pWant to buy happiness? Splurge on these 5 things
2:05pNote to parents: This social network was rated the worst for teenage cyberbullying
2:05pPreserving a fruitful retirement
2:04pThis is the deadliest time of your life to put on weight
2:03pThe dark side of cruises
2:03p5 reasons why millennials can’t have nice things (or save any money)
2:03pWhat Eleanor Roosevelt and Helen Gurley Brown ate — and what we can learn from it 
2:03p7 money-making lessons from the richest man who ever lived
2:03p‘Property Brothers’ is inspiring homeowners to remodel — but creating fictional expectations about how much it costs
2:01pThis week’s retirement news
2:01pHollywood is using social causes to sell movie tickets 
1:49pGold marks highest settlement in a month, up over 2% for the week
1:48pSpicer says in a tweet he'll continue in job through August
1:43pGold prices end at highest level in a month, up over 2% for the week
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,564.04

-47.74
-0.22%





nasdaq

/quotes/zigman/12633936/realtime
6,381.49

-8.51
-0.13%





s&p 500

/quotes/zigman/3870025/realtime
2,470.52

-2.93
-0.12%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15























































Pluristem Therapeutics Inc (PLRS.F)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Pluristem Therapeutics Inc (PLRS.F)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				PLRS.F on Frankfurt Stock Exchange


				1.07EUR
10:14am EDT





				    Change	(% chg)


		    
						    €0.06


					            (+6.26%)
					        






Prev Close

€1.01


Open

€0.99




Day's High

€1.07


Day's Low

€0.99




Volume

100


Avg. Vol

475




52-wk High

€1.55


52-wk Low

€0.99











					Summary





Name
Age
Since
Current Position




							Yaky Yanay

45
2017

                                Chairman of the Board, Chief Executive Officer




							Zalman Aberman

61
2017

                                President, Co-Chief Executive Officer, Director




							Erez Egozi

49
2017

                                Chief Financial Officer




							Doron Shorrer

62
2006

                                Lead Independent Director




							Moria Kwiat

36
2012

                                Director




							Hava Meretzki

46
2005

                                Director




							Israel Ben-Yoram

55
2005

                                Independent Director




							Issac Braun

63
2014

                                Independent Director




							Mark Germain

65
2014

                                Independent Director




							Nachum Rosman

69
2007

                                Independent Director




							Karine Kleinhaus


2013

                                Divisional Vice President, North-America



» Insider Trading





					Biographies





Name
Description




							Yaky Yanay


					
							Mr. Yaky Yanay is Chairman of the Board, Chief Executive Officer of Pluristem Therapeutics Inc. His work experience includes the following roles: President, Chief Operating Officer at the Company (from February 4, 2014), Chief Financial Officer and Secretary at the Company (from November 1, 2006),Chief Financial Officer of Elbit Vision Systems Ltd. and Co-Chairman of Israel Advanced Technology Industries an umbrella organization representing Israel’s hi-tech and life-science industries. He holds a Bachelor of Business Administration degree from Hamichlala Leminhal. He is a Certified Public Accountant.




							Zalman Aberman


					
							Mr. Zalman (Zami) Aberman is President, Co-Chief Executive Officer, Director of Pluristem Therapeutics, Inc. He changed the Company’s strategy towards cellular therapeutics. Mr. Aberman’s vision to use the maternal section of the Placenta (Decidua) as a source for cell therapy, combined with the Company’s 3D culturing technology, led to the development of our products. Since November 2005, Mr. Aberman has served as a director of the Company, and since April 2006, as Chairman of the Board. He has 25 years of experience in marketing and management in the high technology industry. Mr. Aberman has held positions of CEO and Chairman positions in companies in Israel, the United States, Europe, Japan and Korea. Mr. Aberman operated within high-tech global companies in the fields of automatic optical inspection, network security, video over IP, software, chip design and robotics. He serves as the Chairman of Rose Hitech Ltd., a private investment company. He served in the past as the Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP and as a director of Ori Software Ltd., a company involved in data management. Prior to that, Mr. Aberman served as the President and CEO of Elbit Vision System Ltd. (EVSNF.OB), a company engaged in automatic optical inspection. Prior to his service with the Company, Mr. Aberman served as President and CEO of Netect Ltd., specializing in the field of internet security software and was the Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing. He also served as Chairman of Display Inspection Systems Inc., specializing in laser based inspection machines and as President and CEO of Robomatix Technologies Ltd.




							Erez Egozi


					
							Mr. Erez Egozi has been appointed Chief Financial Officer at Pluristem Therapeutics Inc. effective March 29, 2017. His work experience includes the following roles: Vice President - Finance and Secretary at the Company, Senior Director of Finance-worldwide Finance Controller at Verint's Communications and Cyber Intelligence Solutions division, has held several financial positions at Intel Corporation (2003-2007) and Auditor in the hi-tech technology sector at Deloitte & Touche (2000-2003).




							Doron Shorrer


					
							Mr. Doron Shorrer, CPA, is Lead Independent Director of Pluristem Therapeutics, Inc. Mr. Shorrer was one of the Company’s founders and served as its first Chairman until 2006. Mr. Shorrer also serves as a director of other companies: Provident Fund for employees of the Israel Electric Company Ltd. and for Hebrew University employees, and Massad Bank from the International Bank group. Between 1999 and 2004 he was Chairman of the Boards of Phoenix Insurance Company, one of the largest insurance companies in Israel, and of Mivtachim Pension Funds Group, the largest pension fund in Israel. Prior to serving in these positions, Mr. Shorrer held senior positions that included Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the board of directors of “Nechasim” of the State of Israel; Member Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Founder and managing partner of an accounting firm with offices in Jerusalem, Tel-Aviv and Haifa; Member of the Lecture Staff of the Hebrew University Business Administration School; Chairman of Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy. Among many areas of expertise, Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration (specialization in finance and banking) from the Hebrew University of Jerusalem and is a Certified Public Accountant in Israel.




							Moria Kwiat


					
							Dr. Moria Kwiat serves as Director of Pluristem Therapeutics, Inc. Dr. Kwiat holds a B.Sc and an M.Sc. in Biotechnology from Tel Aviv University, and a Ph.D. from the Tel Aviv University Center for Nanoscience and Nanotechnology. Dr. Kwiat served as a teaching assistant at Tel Aviv University from 2003 through 2012. Currently, Dr. Kwiat is a postdoc fellow at the Faculty of Chemistry of Tel Aviv University, working on the development of new generation of biosensors based on nano-materials.




							Hava Meretzki


					
							Ms. Hava Meretzki is Director of Pluristem Therapeutics, Inc. Ms. Meretzki is an attorney and is a partner in Meretzki law firm in Haifa, Israel. Ms. Meretzki specializes in civil, trade and labor law, and is presently the Chairman of the National Council of the Israel Bar Association. Ms. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991 and was admitted to the Israel Bar Association in 1993. We believe that Ms. Meretzki’s qualifications to sit on our Board include her years of experience with legal and corporate governance matters.




							Israel Ben-Yoram


					
							Mr. Israel Ben-Yoram is Independent Director of Pluristem Therapeutics, Inc. He has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel since 1985. In addition, since 1992, Mr. Ben-Yoram has been a shareholder and has served as the head director of Mor, Ben-Yoram Ltd., a private company in Israel in parallel to the operation of Mor, Ben-Yoram and Partners. This company provides management services, economic consulting services and other professional services to businesses. Furthermore, Mr. Ben-Yoram is the CEO of Eshed Dash Ltd. and Zonbit Ltd. During 2003-2004 Mr. Ben-Yoram served as a director of Brainstorm Cell Therapeutics Inc. (BCLI) and Smart Energy solutions, Inc. (SMGY), both of which were traded on the NASDAQ.




							Issac Braun


					
							Mr. Issac Braun is Independent Director of Pluristem Therapeutics, Inc. Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience. He is a co-founder and has been a board member of several hi-tech start-ups in the areas of e-commerce, security, messaging, search engines and biotechnology. Mr. Braun is involved with advising private companies on raising capital and business development.




							Mark Germain


					
							Mr. Mark S. Germain is Independent Director of Pluristem Therapeutics, Inc. Between May 2007 and February 2009, Mr. Germain served as Co-Chairman of our Board. For more than five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries. He has been involved as a founder, director, chairman of the board of, and/or investor in, over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions. He graduated from New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law before leaving in 1986. Since then, and until he entered the biotech field in 1991, he served in senior executive capacities, including as president of a public company, which was sold in 1991. In addition to being a Director of the Company, Mr. Germain is a director of ChromaDex, Inc. (CDXB.OB), a publicly traded company. Mr. Germain also serves as a director of the following companies that were reporting companies in the past: Stem Cell Innovations, Inc., Omnimmune Corp. and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companies in and outside the biotechnology field.




							Nachum Rosman


					
							Mr. Nachum Rosman is Independent Director of Pluristem Therapeutics, Inc. He provides management and consulting services to startup companies in the financial, organizational and human resource aspects of their operations. Mr. Rosman also serves as a director at several privately held companies. Throughout his career, Mr. Rosman held CEO and CFO positions in Israel, the United States and England. In these positions he was responsible, among other things, for finance management, fund raising, acquisitions and technology sales. Mr. Rosman holds a B.Sc. in Management Engineering and an M.Sc. in Operations Research from the Technion, Haifa, Israel. Mr. Rosman also participated in a Ph.D. program in Investments and Financing at the Tel Aviv University, Israel.




							Karine Kleinhaus


					
							Ms. Karine Kleinhaus, M.D., is Divisional Vice President, North America of Pluristem Therapeutics, Inc. She has worked with multiple public and private biotechnology companies on both public and investor relations. Prior to that, she was an Assistant Professor in the Departments of Obstetrics and Gynecology and Psychiatry at the NYU School of Medicine. At NYU, Dr. Kleinhaus conducted medical research funded under a multi-year NIH grant. She published more than 25 papers in leading peer-reviewed journals such as the Annals of the New York Academy of Science, American Journal of Medical Genetics, and the American Journal of Epidemiology. Before that Dr. Kleinhaus practiced obstetrics and then completed two fellowships at Columbia University. Dr. Kleinhaus received her medical degree from Tel Aviv University, earned a Master of Public Health from Columbia’s Mailman School of Public Health, and a bachelor’s degree, cum laude, from Princeton University.











					Basic Compensation





Name
Fiscal Year Total




							Yaky Yanay

786,721




							Zalman Aberman

1,015,210




							Erez Egozi

--




							Doron Shorrer

--




							Moria Kwiat

--




							Hava Meretzki

--




							Israel Ben-Yoram

--




							Issac Braun

--




							Mark Germain

--




							Nachum Rosman

--




							Karine Kleinhaus

--



As Of 
29 Jun 2015





					Options Compensation





Name
Options
Value




							Yaky Yanay

0
0




							Zalman Aberman

0
0




							Erez Egozi

0
0




							Doron Shorrer

12,851,170
0




							Moria Kwiat

0
0




							Hava Meretzki

0
0




							Israel Ben-Yoram

8,355,089
0




							Issac Braun

8,284,594
0




							Mark Germain

0
0




							Nachum Rosman

0
0




							Karine Kleinhaus

0
0









					Insider Trading












Name
Shares Traded
Price


Egozi (Erez)
150,000
$0.00


Aberman (Zalman)
2,000,000
$0.00


Yanay (Yaky)
2,000,000
$0.00


Rosman (Nachum)
66,500
$0.00


Meretzki Klemperer (Hava)
45,000
$0.00


Aberman (Zalman)
200,000
$0.00


Kwiat (Moria)
45,000
$0.00


Germain (Mark S)
65,500
$0.00


Ben-Yoram (Israel)
66,500
$0.00


Braun (Isaac)
45,000
$0.00


Yanay (Yaky)
200,000
$0.00


Shorrer (Doron)
66,500
$0.00


Shorrer (Doron)
12,346
$1.52


Aberman (Zalman)
5,000
$1.33


Yanay (Yaky)
5,000
$1.20


Aberman (Zalman)
9,000
$1.07


Aberman (Zalman)
6,000
$1.06


Yanay (Yaky)
7,500
$0.83


Yanay (Yaky)
7,500
$1.07


Yanay (Yaky)
5,000
$0.83


Ben-Yoram (Israel)
10,000
$0.79


Aberman (Zalman)
31,000
$0.80


Ben-Yoram (Israel)
49,000
$0.00


Meretzki Klemperer (Hava)
35,000
$0.00


Yanay (Yaky)
150,000
$0.00




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research





















Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















People: Pluristem Therapeutics Inc (PSTI.O)





Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				PSTI.O on Consolidated Issue listed on NASDAQ Capital Market


				1.20USD
21 Jul 2017





				    Change	(% chg)


		    
						    $0.02


					            (+1.69%)
					        






Prev Close

$1.18


Open

$1.19




Day's High

$1.25


Day's Low

$1.19




Volume

99,394


Avg. Vol

238,738




52-wk High

$1.85


52-wk Low

$1.04










	Meretzki, Hava 





	Ms. Hava Meretzki is Director of Pluristem Therapeutics, Inc. Ms. Meretzki is an attorney and is a partner in Meretzki law firm in Haifa, Israel. Ms. Meretzki specializes in civil, trade and labor law, and is presently the Chairman of the National Council of the Israel Bar Association. Ms. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991 and was admitted to the Israel Bar Association in 1993. We believe that Ms. Meretzki’s qualifications to sit on our Board include her years of experience with legal and corporate governance matters.



Basic Compensation




Total Annual Compensation, 
--


Restricted Stock Awards, 
--


Long-Term Incentive Plans, 
--


All Other, 
--


Fiscal Year Total, 
--








Options Compensation




 
Quantity
Market Value


Exercisable
--
--


Unexercisable
--
--


Exercised
--
--














					Basic Compensation






Name
Fiscal Year Total




							Yaky Yanay

786,721




							Zalman Aberman

1,015,210




							Erez Egozi

--




							Doron Shorrer

--




							Moria Kwiat

--




							Hava Meretzki

--



As Of 
29 Jun 2015

» View All Officers
















Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research






















Pluristem Therapeutics Inc. company : Shareholders, managers and business summary | Nasdaq: PSTI | 4-Traders














































































 




Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON








 








Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East� More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100� More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD� More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM� More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 







4-Traders Homepage  >  Equities  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI DOWNLOAD REPORT










     PLURISTEM THERAPEUTICS INC. (PSTI)     


Add to my list    

Mes derni�res consult.Most popular
Manage my lists

















 







 Delayed  - 07/21 07:47:30 pm

1.21
USD
 
+2.54%










07/10 Pluristem Advances its Multinational Phase III Critical Limb Isch..


06/29 Pluristem to Present New Data from ARS study at Radiology Confere..


06/23 PLURISTEM THERA : PSTI) Files An 8-K Departure of Directors or Certa..

 







SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 


















 










Business Summary


Develops stem cell production technologyPluristem Therapeutics, Inc. is a biotechnology company engages in the provision of cell therapy development.It focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others.Its products include PLacental eXpanded, PLX-PAD, and PLX-R18.The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
Number of employees : 169 persons.
 





Sales per Businesses











20152016DeltaUSD (in Million)%USD (in Million)%Cell Therapeutics and Related Technologies0.379100%2.85100% +651.19%



Sales per Regions











20152016DeltaUSD (in Million)%USD (in Million)%Global0.379100%2.85100% +651.19%



Managers










 NameAgeSinceTitleZami Aberman622005Chairman & Co-Chief Executive OfficerYaky Yanay462006President, Co-Chief Executive Officer & DirectorSagi Moran--Vice President-OperationsErez Egozi-2017Chief Financial Officer & TreasurerEsther Lukasiewicz-Hagai MD, PhD--Vice President-Clinical & Medical AffairsMark S. Germain662007DirectorNachum Rosman702007Independent DirectorIsrael Ben-Yoram, MBA552005Independent DirectorIsaac Braun632005DirectorHava Klemperer Meretzki472003Director 



Equities


 











Vote QuantityFloatCompany-owned sharesTotal Float


Share A
1
96,331,182
86,099,489
89.4%
0
0.0%
89.4% 

 


Shareholders









 NameEquities%Zami Aberman 4,429,698
                4.60%Yaky Yanay 3,718,115
                3.86%Renaissance Technologies LLC                1,553,800
                1.61%Menora Mivtachim Insurance Ltd.                1,000,000
                1.04%Doron Shorrer, MBA 636,708
                0.66%Migdal Mutual Funds Ltd.                576,724
                0.60%Israel Ben-Yoram, MBA 494,306
                0.51%Mark S. Germain 452,635
                0.47%Hava Klemperer Meretzki 415,208
                0.43%Isaac Braun 415,208
                0.43% 
 







Sector
HealthcarePharmaceuticals & Medical Research Biotechnology & Medical Research  Biotechnology & Medical Research   Biotechnology & Medical Research - NEC
 





Sector Biotechnology & Medical Research - NEC


1st jan.Capitalization (M$)

PLURISTEM THERAPEUTICS INC.-17.48%114





INCYTE CORPORATION33.43%27 397

QUINTILES IMS HOLDINGS INC19.61%19 489

LONZA GROUP33.19%16 967

CELLTRION, INC.--.--%12 547

ALKERMES PLC3.51%8 813

QIAGEN NV18.74%7 975

SEATTLE GENETICS, INC.2.33%7 727

ALNYLAM PHARMACEUTICALS, INC.109.56%7 366

IONIS PHARMACEUTICALS INC13.78%6 925

UNITED THERAPEUTICS CORPORATION-8.42%5 919

ICON PLC32.71%5 367

CHARLES RIVER LABORATORIES INTL. INC32.69%4 816

PRA HEALTH SCIENCES INC38.32%4 763

EXACT SCIENCES CORPORATION192.22%4 614

PAREXEL INTERNATIONAL CORPORATION32.93%4 435

BIO-TECHNE CORP13.71%4 365

GALAPAGOS11.08%4 005

PORTOLA PHARMACEUTICALS INC190.95%3 723

ACADIA PHARMACEUTICALS INC.4.33%3 672

PUMA BIOTECHNOLOGY INC208.63%3 503


Sector Biotechnology & Medical Research - NEC
 


Connections : Pluristem Therapeutics Inc



Elbit Vision Systems Ltd.








Yaky Yanay



Rose Hitech Ltd.








Zami Aberman




Israel Advanced Technology Industries








Yaky Yanay




Mor, Ben-Yoram Ltd.








Israel Ben-Yoram




Eyecue Vision Technologies Ltd.








Yaky Yanay




Alliance for Regenerative Medicine








Zami Aberman




Talecity Ltd.








Nachum Rosman




Meretzki-Tavor








Hava Klemperer Meretzki




Eshed Dash Ltd.








Israel Ben-Yoram




Simba Ltd.








Nachum Rosman




Omnimmune Corp.








Mark S. Germain




Zoomix Data Mastering Ltd.








Nachum Rosman




Amphioxus Cell Technologies, Inc.








Mark S. Germain




Zonbit Ltd.








Israel Ben-Yoram




The Olmsted Group








Mark S. Germain




Society of Trust & Estate Practitioners Ltd.








Israel Ben-Yoram




Multiview Ltd.








Nachum Rosman




Israel Bar Association








Hava Klemperer Meretzki






Company contact information
Pluristem Therapeutics, Inc.MATAM Advanced Technology ParkBuilding No. 5Haifa 31905Phone : +972.74.710.8600Fax : +972.74.710.8787Web : www.pluristem.com
 


            © 2017 People , Fundamentals and Ownership    








 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :B�rse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright � 2017 Surperformance. All rights reserved.  









 


  














Slave





 



Pluristem Expands Board of Directors; Appoints Seasoned Professionals to Provide Strategic Direction in Meeting Aggressive Growth Objectives | Business Wire


























































Pluristem Expands Board of Directors; Appoints Seasoned Professionals to Provide Strategic Direction in Meeting Aggressive Growth Objectives






October 09, 2003 09:43 AM Eastern Daylight Time



				HAIFA, Israel--(BUSINESS WIRE)--Oct. 9, 2003--Pluristem Life Sciences, Inc. (OTC BB:PLRS), a biotechnology company dedicated to the expansion of stem cells to address a myriad of fatal illnesses, today announced that the Company has expanded its Board of Directors through the appointment of Doron Shorrer, CPA, (ISR) as Chairman, Hava Klemperer Meretzki, and Robert J. Pico to assist in providing strategic direction in meeting aggressive growth objectives.  Doron Shorrer, ISR (CPA) was Chairman of the Board of Phoenix Insurance Company, one of the largest insurance companies in Israel and Mivtachim Pension Benefit Group, the largest pension fund in Israel managing $15 billion. Before assuming these positions, Shorrer held senior appointments that included,: Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the Board of Directors of "Nechasim" of the State of Israel; Member of the Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Co-Founder and Director of an accounting firm having three branches (Jerusalem, Tel-Aviv, Haifa),;Member of the Lecture Staff of the Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.  Among many areas of expertise, Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector. He additionally consults on economic, accounting and taxation issues to a large audience ranging from private concerns to government ministries. Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration (specialization in finance and banking) from the Hebrew University of Jerusalem. He is a Certified Public Accountant (ISR).  Hava Klemperer Meretzki, Adv. is a partner in the law firm of Ben-Noun Meretzki in Haifa, Israel. She specializes in civil, trade and labor law and is presently Vice-Chairman for the National Council of the Israel Bar Association. She previously was a Director of the Israel Electric Company. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991, and in 1992 was admitted to the Israel Bar Association.  Robert J. Pico is presently Vice President of Business Development at TranSwitch Corporation (NASDAQ:TXCC). He leads all M&A activities and initialization of start-up companies through seed funding for companies that include: Teraop, Optix, IC41C, Onex (acquired by TXCC), SOSI (acquired by TXCC). Mr. Pico additionally invests on behalf of TranSwitch in companies that demonstrate significant growth opportunities including Accordian Networks. He performs all contract negotiations for TranSwitch when acquiring third party intellectual property such as VLSI cell libraries and semiconductor foundry service contracts from suppliers such as Texas Instruments (NYSE:TXN), TSMC in Taiwan and LSI Logic (NYSE:LSI). Mr. Pico has led the TranSwitch team consummating more than 10 acquisitions and formation of start-up companies spanning Israel, North America, Europe, and Asia. He is a Board member of several of these companies. Pico joined TranSwitch in 1988 and assisted in its public offering in 1995 on the NASDAQ Exchange.  Mr. Pico has a breadth of corporate management expertise spanning engineering, operations and business development. Prior to his tenure at TranSwitch he held senior positions in both large multi-national corporations such as ITT and United Technologies. He holds a BSEE and MS in Physics from the University of Hartford and Trinity College respectively and has completed his requirements for an MBA in Marketing from the University of Hartford.  Irit Arbel, CEO, commented, "We are most pleased that Doron Shorrer, Hava Meretzki and Robert Pico have accepted appointments to the Board of Directors. Their backgrounds in law, accounting, mergers and acquisitions, start-up entities and advising corporations and governments, we believe, will be of great assistance to Pluristem as the company continues to meet milestones and plans for future activities such as strategic alliances, joint ventures and the many opportunities that lie ahead."  About Pluristem  Pluristem is a biotechnology company dedicated to the development of stem cell expansion technology. The Company is concentrating on the expansion of cord blood hematopoietic stem cells and may provide, upon successful development and regulatory approval, critical cell expansion services to blood banks and transplants centers in the U.S. and Europe  Safe Harbor Statement  Statements in this document that are not purely historical are forward-looking statements. Forward-looking statements in this release include statements regarding: our developing stem cell technology into a useful product that could address fatal illnesses,and that our new board members will help us meet our milestones and plans. Actual outcomes and our actual results could differ materially from those in such forward-looking statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to complete its obligations under the stem cell license agreement, inability to finance the planned development of the technology, inability to obtain regulatory approval for commercial use of our products and unforeseen technical difficulties in developing the stem cell technology, and inability to keep our directors and management, which could among other things, delay or prevent product release. For further risk factors see our 8-K filed with the SEC June 25, 2003.


Contacts
					DeMonte Associates, New YorkCynthia DeMonte, 212-605-0525cdemonte@demonte.com












Contacts
			DeMonte Associates, New YorkCynthia DeMonte, 212-605-0525cdemonte@demonte.com






 
 

 






Search




Advanced News Search

Advanced News Search













Log In
Sign Up















		The Company - Pluristem Therapeutics Inc.  Pluristem Therapeutics Inc.	

















































Pluristem Therapeutics Inc.







Company
Products 

PLX Products
Pipeline – PLX-PAD

Critical Limb Ischemia
Intermittent Claudication
Orthopedic Indications
Pulmonary Arterial Hypertension
Women’s Health


Pipeline – PLX-R18

Hematology
Acute Radiation Syndrome




Clinical Programs 

Clinical Development Strategy
Critical Limb Ischemia (CLI)
Intermittent Claudication (IC)
Muscle Injury
Acute Radiation Syndrome (ARS)
Hematopoietic cell Transplantation
Pulmonary Arterial Hypertension (PAH)


Science & Technology 

Mechanism of Action
3D Manufacturing Platform
Placenta
Intellectual Property
Additional Technologies
Preclinical Programs
Scientific Publications


Collaborations 

Partnering strategy
Industry Partners
Academic Partners


Investors & Media 

News
From the Media
Events
Presentations
Financial Statements
SEC Filing
Covering Analysts
Corporate Governance
IR Team























Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation.








Our vision
Our vision is to leverage our advanced technology and our position as a global leader in cell therapy to develop and manufacture highly effective cell products that will heal patients around the world.
Our strategy
Our strategy is to develop powerful cell therapies that can be successfully commercialized to reach patients who need innovative treatment options. We develop placenta-derived, “off-the-shelf” products that do not need genetic or tissue matching prior to administration and could be delivered in almost any clinical setting. We design distinct cell products to target a variety of indications, and anticipate that a pipeline of differentiated products and indications will allow us to target large global markets. We explore new partnerships to advance our clinical development programs, while maintaining our strong commitment to current corporate, academic and government collaborations.







Management Team
















Zami Aberman
Chairman & Co-CEO








Zami Aberman joined Pluristem in September 2005, and redirected the Company's strategy towards cellular therapeutics to become one of the global leaders in the industry. Mr. Aberman's vision to use the maternal portion of the placenta as a cell source for Pluristem’s products, combined with Pluristem's 3D culturing technology, led to the development of the Company's unique therapies. In 2013 the World Stem Cells Regenerative Medicine Congress ranked Mr. Aberman as one of the 50 most influential people in the stem cells space. Prior to Pluristem, Mr. Aberman had a 30 year career as a senior executive in the high-tech industry with multiple companies in Israel, the U.S., Europe, Japan and Korea. Previous roles include Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP; Director of Ori Software Ltd., a company involved in data management; President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronics industry; President and CEO of Netect Ltd., a company specializing in the field of internet security software; Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing; Chairman of Display Inspection Systems Inc., a company specializing in laser based inspection machines; and President and CEO of Robomatix Technologies Ltd. (RBMXF.OB). In addition to his current role at Pluristem, Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.                                                












Yaky Yanay
Co-CEO and President








Yaky Yanay was appointed as our President from February 2014 and as our Co-CEO from March 2017. Mr. Yanay served as our Chief Financial Officer from November 2006 until February 2014 and from February 2015 until March 2017. He also served as our Chief Operating Officer from February 2014 until March 2017. Until February 2014, he also served as our Secretary since November 2006, and Executive Vice President since March 2013. Before joining Pluristem, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst & Young Israel. Mr. Yanay is Co-Chairman of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s high tech and life science industries. Yanay is representing Israel’s life sciences industry and has served on the Board of Directors of IATI for the past four years. Mr. Yanay also founded and served as Chairman of the “The Life Science Forum”. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.                                                












Efrat Livne-Hadass
VP Human Resources








Efrat Livne-Hadass joined Pluristem in 2007 and is responsible for all aspects of Human Resources management, including recruitment, professional training, and well-being.
Prior to joining Pluristem and during the years 2001-2005, Ms. Livne-Hadass held the position of Human Resources Manager at Elbit Vision Systems, a company engaged in automatic optical inspection, located in Yokneam, Israel. While holding that position, she was involved in some major challenges and change processes which the company was going through, including managing HR in a small yet global public company.
Ms. Livne-Hadass holds an Executive M.A. for Human Resources managers from the department of Labor Studies, Tel-Aviv University and a B.Sw. degree from the Haifa University, majoring in public healthcare services.                                                












Hillit Mannor Shachar, M.D.
VP Business Development








Hillit Mannor Shachar, M.D., joined Pluristem in October 2013 as VP of Business Development. Prior to joining Pluristem, Dr. Shachar had over ten years' experience in both business development and corporate development having worked and consulted at companies including West Pharmaceutical Services, Nektar Therapeutics, Orex Computer Radiography (acquired by Kodak) and Transpharma Medical. Dr. Shachar worked at Apax Partners as a healthcare associate and at Deloitte Israel as a consultant in their life science practice.
Dr. Shachar graduated from Northwestern University's Honors Program in Medical Education and holds a B.A. and M.D. from there. In addition, she holds a M.B.A. from Kellogg Recanati Executive Program and an MSFS from Georgetown University.                                                












Erez Egozi
CFO








Mr. Erez Egozi was appointed Chief Financial Officer in March 2017, and as Secretary in September 2015. Prior to his appointment as CFO, Mr. Egozi was our Vice President of Finance from March 2015 until March 2017. Before Joining Pluristem, from 2007 to 2015, Mr. Egozi held several senior financial positions at Verint Systems Inc (Nasdaq:VRNT), including as senior director of finance - worldwide finance controller of Verint's Communications and Cyber Intelligence Solutions division. From 2003 to 2007, Mr. Egozi held several financial positions at Intel Corporation (Nasdaq:INTC). From 2000 to 2003, Mr Egozi served as an auditor in the high tech technology sector at Deloitte & Touche.  Mr. Egozi holds a bachelor's degree in economics and accounting from Beer-Sheva University, and a M.A. degree in law from Bar-Ilan University, and is a certified public accountant in Israel.                                                












Esther Lukasiewicz Hagai, M.D., Ph.D.
VP Clinical & Medical Affairs








Dr. Lukasiewicz-Hagai has twelve years' experience in Drug development. She joins Pluristem from Teva Global R&D, where she was Director, Clinical Program Leader, leading the global clinical development of multiple biosimilars and innovative drugs in various Oncologic and Neuropsychiatric indications. She previously worked at Gertner Institute for Epidemiology and Health Policy Research (Sheba Medical Center, Tel Hashomer) where she was responsible of multiple national and US-Israeli clinical trials in Orthopedic and Hemato-Oncologic indications. Dr Lukasiewicz-Hagai holds a M.D. and a Medical Residency in Public Health and Social Medicine from Necker-Enfants Malades Paris V School of Medicine In addition, she holds a Master of Methodology and Statistics in Clinical Research and a M. Med. Sc. in Biostatistics and Epidemiology from Paris XI as well as a Ph.D. in Biostatistics from Bar-Ilan University.                                                












Sagi Moran, M.B.A.
VP Operations








Sagi Moran, joined Pluristem in June 2014 as VP of Operations. Prior to joining Pluristem, Mr. Moran served as the CTO for LASER medical device startup AxonoGen Ltd., and as COO for NovoXel Ltd.
Mr. Moran established a medical division for Qualitest Group Ltd., the largest engineering and testing services group for the medical industry in Israel. The division provides services for pharmaceutical and medical companies, such as TEVA, PHILIPS healthcare, GE, UltraShape, Given Imaging and others. Prior to that Mr. Moran served for 10 years in Lumenis Ltd. In key global managerial position in R&D and Operations.
Mr. Moran holds a Master of Business Administration (MBA) from Recanati Executive MBA program at Tel-Aviv University, and a bachelor’s degree in Information Systems from Haifa University.                                                












Orly Amiran
VP Quality Assurance








Orly Amiran holds a master degree in Quality Assurance from the Technion and a B.Sc. in Pharmacy from the Hebrew University. She has worked in the pharmaceutical industry since 2001 and has extensive experience in Quality Assurance management in global companies which market drugs to the European market and to North America.
Prior to joining Pluristem Orly held the positions of Quality Assurance Manager at TEVA and Compliance Manager at Taro. She played a central role in successful regulatory agencies inspections in both positions.

Ms. Orly Amiran brings with her to Pluristem a vast experience and knowledge on GMP, quality regulations and the corresponding industry best practices.                                                












Racheli Ofir, Ph.D., MA. Law
VP Research & Intellectual Property








Racheli Ofir Joined Pluristem in 2007, serves as Vice President of research and intellectual property. The Research Department examines the various cells developed by the company, the properties of those cells and their mechanisms of action by using molecular methods and animal models to test the safety and efficacy. The IP department is responsible for intellectual property strategy development as well as the research that supports the IP.
Dr. Ofir is responsible for leading projects involving the characterization of PLX cells, Pluristem's leading placenta derived cell product candidate, including evaluating the biological activity of the cells in in-vitro and animal studies. She is responsible for the studies which determines the safety profile and pharmacokinetics of PLX cells. In addition, she is in charge of all pre-clinical aspects of the PLX regulatory process and for the communications with the relevant regulatory authorities (FDA, EMA and PEI).
Dr. Ofir is also responsible for applying and prosecuting over ten patent families filed worldwide, a co-inventor on five patent applications and the co-author of numerous peer reviewed articles.
Dr. Ofir earned her Ph.D. from the Technion, Israel institute of technology, where she investigated Telomeric position effects on gene expression and DNA replication in Human cells. She did her postdoctoral fellowship at the Technion in molecular embryology investigating genes involved in early development of vertebrates' nervous system.
Dr. Ofir has extensive research experience in molecular cell biology, embryology and cytogenetics as well as broad professional experience in the field of human cell therapy.                                                












Lior Raviv
VP Development








Lior Raviv joined Pluristem in 2011 and currently serves as Vice President of Development. Prior to that Mr. Raviv served as Process development engineer and Projects manager & Product development Team leader at Pluristem. Prior to joining Pluristem and during the years 2010-2011, Mr Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries.
Mr. Raviv holds a M.Med.Sec in pharmacology from the Ben Gurion University and a B.S.c, in Biotechnology engineering from the Ben Gurion University.                                                












Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North America








Karine Kleinhaus, M.D., M.P.H., is Divisional Vice President, North America at Pluristem Therapeutics. She has worked with multiple public and private biotechnology companies, and prior to that she was an Assistant Professor in the Departments of Obstetrics and Gynecology and Psychiatry at the NYU School of Medicine. At NYU, Dr. Kleinhaus conducted medical research funded under a multi-year NIH grant. She published more than 25 papers in leading peer-reviewed journals such as the Annals of the New York Academy of Science, American Journal of Medical Genetics, and the American Journal of Epidemiology. Before that Dr. Kleinhaus practiced obstetrics and then completed two fellowships at Columbia University.
Dr. Kleinhaus received her medical degree from Tel Aviv University, earned a Master of Public Health from Columbia’s Mailman School of Public Health, and a bachelor’s degree, cum laude, from Princeton University.                                                












Board







Zami Aberman 






Mr. Zami Aberman joined Pluristem in September 2005, and redirected the Company's strategy towards cellular therapeutics to become one of the global leaders in the industry. Mr. Aberman's vision to use the maternal portion of the placenta as a cell source for Pluristem’s products, combined with Pluristem's 3D culturing technology, led to the development of the Company's unique therapies. In 2013 the World Stem Cells Regenerative Medicine Congress ranked Mr. Aberman as one of the 50 most influential people in the stem cells space. Prior to Pluristem, Mr. Aberman had a 30 year career as a senior executive in the high-tech industry with multiple companies in Israel, the U.S., Europe, Japan and Korea. Previous roles include Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP; Director of Ori Software Ltd., a company involved in data management; President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronics industry; President and CEO of Netect Ltd., a company specializing in the field of internet security software; Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing; Chairman of Display Inspection Systems Inc., a company specializing in laser based inspection machines; and President and CEO of Robomatix Technologies Ltd. (RBMXF.OB). In addition to his current role at Pluristem, Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.													





Yaky Yanay 






Mr. Yaky Yanay was appointed as Pluristem’s President in February 2014 and as Co-CEO from March 2017. Mr. Yanay served as our Chief Financial Officer from November 2006 until February 2014 and from February 2015 until March 2017. He also served as our Chief Operating Officer from February 2014 until March 2017. Until February 2014, he also served as our Secretary since November 2006, and Executive Vice President since March 2013. Before joining Pluristem, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst & Young Israel. Mr. Yanay is Co-Chairman of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s high tech and life science industries. Yanay is representing Israel’s life sciences industry and has served on the Board of Directors of IATI for the past four years. Mr. Yanay also founded and served as Chairman of the “The Life Science Forum”. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.													





Mark Germain 






Mr. Mark Germain has served as a Director on the Board of Directors since May 17, 2007. For more than the past five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries.
He has been involved as a founder, director, Chairman of the Board, and/or investor in over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions. He graduated New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law. From 1986 to 1991 he served in senior executive capacities, including as president of a public company that was sold in 1991, at which time he entered the biotech field.
In addition to being Co-Chairman at Pluristem, Mr. Germain is a director of the following publicly traded companies: Wellford Real Properties, Inc., Stem Cell Innovations, Inc., and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companies in the biotechnology field.													





Hava Klemperer Meretzki 






Mrs. Hava Klemperer Meretzki, Adv. is a partner in the law firm of Ben-Noun Meretzki in Haifa, Israel. She specializes in civil, trade and labor law and is presently Vice-Chairman for the National Council of the Israel Bar Association. She previously was a Director of the Israel Electric Company. Ms. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991, and in 1992, was admitted to the Israel Bar Association.													





Doron Shorrer 






Mr. Doron Shorrer (CPA, Israel) was Chairman of the Board of Phoenix Insurance Company, one of the largest insurance companies in Israel and Mivtachim Pension Benefit Group, the largest pension fund in Israel, managing $15 billion. Before assuming these positions, Mr. Shorrer held senior appointments that included: Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the Board of Directors of "Nechasim" of the State of Israel; Member of the Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Co-Founder and Director of an accounting firm having three branches (Jerusalem, Tel-Aviv, Haifa); Member of the Lecture Staff of the Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.
Among many areas of expertise, Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector. Additionally, Mr. Shorrer consults on economic, accounting and taxation issues to a large audience, ranging from private concerns to government ministries. Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration, with a specialization in finance and banking from the Hebrew University of Jerusalem. He is a Certified Public Accountant (ISR).													





Isaac Braun 






Mr. Isaac Braun was appointed a Director of Pluristem on July 6, 2005. Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience. He has been a co-founder and board member of several hi-tech start-ups in the areas of e-commerce, security, messaging, search engines and biotechnology. Mr. Braun advises private companies on raising financing and business development.													





Israel Ben Yoram 






Mr. Israel Ben-Yoram was appointed a director of Pluristem on January 26, 2005. Mr. Ben-Yoram has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel from 1985 to the present. This accounting firm currently employs over 15 employees in the field of auditing, consulting, and associated projects. Since 1992, Mr. Ben-Yoram has served as a shareholder and the head director of Mor, Ben-Yoram Ltd., a private company in Israel, in parallel with the operation of the Mor, Ben-Yoram and Partners accounting firm. This company provides management services, economic consulting services and other professional services to businesses. Mr. Ben-Yoram received a B.A. in accounting from the University of Tel Aviv, an M.A. in Economics from the Hebrew University of Jerusalem, an L.L.B. and an M.B.A. from Tel Aviv University and an L.L.M. from Bar-Ilan University.													





Nachum Rosman 






Mr. Nachum Rosman is an expert in finance, management and organization. He has held Chief Executive and CFO positions in Israel, USA and England. He has operated in high-tech global companies in software and business. In these jobs he was responsible for finance management, fund-raising, acquisitions, technology sales, preparation of financial reports for due diligences, etc.
Mr. Rosman serves as a consultant to start-up companies in financing, strategy and reorganization. He serves as the CEO of Multiview Ltd, a company he co-founded in 1999. He serves as a director at Zoomix data mastering and Knolan.
Mr. Rosman was a director actively involved in the sale of New Dimension Ltd. to B.M.C. Inc. for $ 675 million. Prior to that he held a Co-CEO position in R.T.S. Ltd. (Virinet Ltd.), where he participated in the IPO on NASDAQ.													





Moria Kwiat 






Dr. Moria Kwiat is a Research Fellow in the Department of Materials and NanoSciences, Faculty of Chemistry at Tel Aviv University. During her studies she has gained a broad scientific experience in inter-disciplinary fields, and currently she is working on the development of a new generation of biosensors based on nano-materials. Mrs. Kwiat holds a B.Sc. and M.Sc. in Biotechnology from the Department of Molecular Microbiology and Biotechnology at Tel Aviv University, and a Ph.D. in Nano-Biotechnology from the Faculty of Exact Sciences at Tel Aviv University.													



















PSTI Insider Trading - Pluristem Therapeutics Inc - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Pluristem Therapeutics Inc (PSTI)





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-05-30Sale
2016-06-064:01 pm
Pluristem Therapeutics Inc
PSTI
Shorrer DoronDirector
12,346
$1.521
$18,784
570,208(Indirect)
View


2016-02-22Purchase
2016-02-2407:04 am
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
5,000
$1.33
$6,650
2,118,298(DirectIndirect)
View


2016-02-18Purchase
2016-02-224:02 pm
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
5,000
$1.2
$6,000
1,451,616(DirectIndirect)
View


2016-02-16Purchase
2016-02-174:04 pm
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
15,000
$1.066
$15,990
2,118,298(DirectIndirect)
View


2016-02-16Purchase
2016-02-174:01 pm
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
15,000
$0.95
$14,250
1,451,616(DirectIndirect)
View


2016-02-15Purchase
2016-02-174:00 pm
Pluristem Therapeutics Inc
PSTI
Shorrer DoronDirector
12,346
$0.8074
$9,968
582,554(Indirect)
View


2016-02-11Purchase
2016-02-164:13 pm
Pluristem Therapeutics Inc
PSTI
Ben-yoram IsraelDirector
10,000
$0.79
$7,900
216,056(IndirectDirect)
View


2016-02-12Purchase
2016-02-164:10 pm
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
5,000
$0.8277
$4,139
1,451,616(DirectIndirect)
View


2016-02-11Purchase
2016-02-164:09 pm
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
31,000
$0.7973
$24,716
2,118,298(DirectIndirect)
View


2015-11-16Purchase
2015-11-1707:40 am
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
9,900
$1.49
$14,751
1,968,298(DirectIndirect)
View


2015-11-16Purchase
2015-11-1707:38 am
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
10,000
$1.52
$15,200
1,301,616(DirectIndirect)
View


2015-09-21Purchase
2015-09-244:02 pm
Pluristem Therapeutics Inc
PSTI
Ben-yoram IsraelDirector
30,000
$2.091
$62,737
206,056(IndirectDirect)
View


2015-09-21Sale
2015-09-244:02 pm
Pluristem Therapeutics Inc
PSTI
Ben-yoram IsraelDirector
30,000
$2.1
$63,000
206,056(IndirectDirect)
View


2015-09-21Purchase
2015-09-214:09 pm
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
10,000
$2.11
$21,100
1,301,616(DirectIndirect)
View


2015-09-21Purchase
2015-09-214:08 pm
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
25,500
$2.109
$53,780
1,968,298(DirectIndirect)
View


2015-09-16Purchase
2015-09-1709:25 am
Pluristem Therapeutics Inc
PSTI
Yanay YakyCOO, CFO & PresidentDirector
10,000
$2.115
$21,155
1,301,616(DirectIndirect)
View


2015-09-15Purchase
2015-09-164:34 pm
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
25,000
$2.11
$52,750
1,968,298(DirectIndirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-29Option Award
2016-12-294:13 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
200,000
$0
2,318,298(Direct)
View


2016-12-29Option Award
2016-12-294:11 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
200,000
$0
1,651,616(Direct)
View


2016-12-29Option Award
2016-12-294:10 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Rosman NachumDirector
66,500
$0
387,464(Indirect)
View


2016-12-29Option Award
2016-12-294:09 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Kwiat MoriaDirector
45,000
$0
187,500(Direct)
View


2016-12-29Option Award
2016-12-294:07 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Germain MarkDirector
65,500
$0
452,635(Direct)
View


2016-12-29Option Award
2016-12-294:06 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Braun IsaacDirector
45,000
$0
415,208(Direct)
View


2016-12-29Option Award
2016-12-294:04 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Ben-yoram IsraelDirector
66,500
$0
278,250(Indirect)
View


2016-12-29Option Award
2016-12-294:02 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Meretzki HavaDirector
45,000
$0
415,208(Direct)
View


2016-12-29Option Award
2016-12-294:00 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Shorrer DoronDirector
66,500
$0
636,708(Indirect)
View


2016-01-05Option Award
2016-01-074:15 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Ben-yoram IsraelDirector
49,000
$0
211,750(Indirect)
View


2016-01-05Option Award
2016-01-074:14 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
150,000
$0
2,118,298(Direct)
View


2016-01-05Option Award
2016-01-074:12 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Yanay YakyCFO, COO & PresidentDirector
150,000
$0
1,451,616(Direct)
View


2016-01-05Option Award
2016-01-074:10 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Rosman NachumDirector
49,000
$0
320,964(Indirect)
View


2016-01-05Option Award
2016-01-074:09 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Kwiat MoriaDirector
35,000
$0
142,500(Direct)
View


2016-01-05Option Award
2016-01-074:08 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Germain MarkDirector
48,000
$0
387,135(Direct)
View


2016-01-05Option Award
2016-01-074:06 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Braun IsaacDirector
35,000
$0
370,208(Direct)
View


2016-01-05Option Award
2016-01-074:05 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Meretzki HavaDirector
35,000
$0
370,208(Direct)
View


2016-01-05Option Award
2016-01-074:03 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Shorrer DoronDirector
49,000
$0
570,208(Indirect)
View


2015-06-28Option Award
2015-06-304:03 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Yanay YakyPresident, COO, CFO
200,000
$0
1,301,616(Direct)
View


2015-06-28Option Award
2015-06-304:02 pm
N/AN/A
Pluristem Therapeutics Inc
PSTI
Aberman ZamiCEO & ChairmanDirector
200,000
$0
1,968,298(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 21 Jul 2017 13:11:52 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  








